Negotiating Equity and Stock Options

Equity is often the most valuable and least understood part of a compensation package. Big equity numbers blind candidates to the details that determine actual value. This guide shows how to evaluate and negotiate equity intelligently, so you understand what you are actually being offered.

Understand what equity actually is

Equity is partial ownership of a company. Stock options give you the right to buy shares at a set price later. Restricted stock units (RSUs) give you shares outright as they vest. The distinction matters enormously: options require you to pay a strike price and have tax complexity; RSUs are simpler but, in many countries including the US, taxed as income when they vest. Understand which you are being offered before valuing it.

Vesting schedules and cliffs

A common arrangement is vesting over four years with a one-year cliff. In that structure you receive nothing for the first year, then 25% at the one-year mark, then the rest in smaller instalments, often monthly. Schedules vary, so read yours. Vesting is a retention mechanism; understand it before accepting. Leaving before the cliff means leaving all equity behind. Some companies offer accelerated vesting on change of control, which can matter in acquisitions.

Strike price and 409A valuation

For options, the strike price is what you pay to exercise. In the US it is usually set at the company's current 409A valuation when you join. If the company's value grows, your options become valuable; if it does not, they may be worth nothing. The strike price is a cost, not a gift. Understand it, and understand that exercising options requires cash you may not have.

What percentage of the company is your grant?

The number of shares is meaningless without knowing the total shares outstanding. Always ask what percentage of the company your grant represents. A grant of 10,000 shares means nothing if there are 100 billion shares. The percentage is what matters. A reputable company will share this; one that will not is a warning sign.

Dilution and future rounds

Your percentage will dilute as the company raises more funding. Each new round issues new shares, reducing your ownership. Understand the company's funding stage, runway, and likely future fundraising. For example, a 0.5% grant at Series A could be diluted to a smaller percentage by exit, depending on how much is raised later. This is normal but should factor into your evaluation.

Evaluate the realistic exit scenarios

Many startups never reach an exit that pays employees. Evaluate the realistic scenarios: acquisition, IPO, or failure. What would your equity be worth in each? What is the company's trajectory, funding, and market? Be honest about the probabilities. Equity can end up worth nothing or a great deal. Evaluate realistically, not hopefully.

Negotiate the equity grant

Equity is negotiable, especially at startups. Negotiate the number of shares, the vesting schedule, and the cliff. At later-stage companies, equity may be less flexible but base salary or signing bonus may compensate. Understand which components have flexibility before negotiating. Always negotiate the percentage, not the share count.

Understand the tax implications

Equity has complex tax implications that vary by country and equity type. Options may trigger taxes on exercise, even before you sell the shares. RSUs are taxed as income at vesting. Early exercise, 83(b) elections in the US, and other rules can dramatically affect after-tax value. Get professional advice for significant grants; mistakes can be expensive.

Ask the questions that matter

Before accepting equity, ask: what percentage of the company is this grant? What is the current 409A valuation? What is the liquidation preference stack? What is the likely exit timeline? How much runway is left? A transparent company answers these; an evasive one is a warning. You are committing years of your career; you deserve to understand the upside.

Key takeaways

• Understand whether you have options or RSUs; the tax and cost implications differ.
• Ask what percentage of the company your grant represents, not just share count.
• Vesting, strike price, and dilution determine actual value, not headline numbers.
• Evaluate realistic exit scenarios; equity can end up worth nothing.
• Ask the hard questions; transparent companies answer, evasive ones warn.